Anaplastic Meningioma
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Predictive Factors for Survival in Aggressive Meningiomas (NCT05793034) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-01-07 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma (NCT03016091) | Rabin Medical Center | 2018-01-01 |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926) | City of Hope Medical Center | 2010-05-01 |
Track Anaplastic Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.